Advertisement

Cell and Tissue Banking

, Volume 19, Issue 4, pp 569–580 | Cite as

A pharmacoeconomic analysis of the collection and preservation of samples in the biobank of the “Instituto Nacional de Cancerología” in Mexico City

  • Luz María Ruíz-Godoy
  • Fabiola Berenice Baez-Revueltas
  • María de Lourdes Suarez-Roa
  • Héctor Maldonado-Martínez
  • Virginia Enriquez-Carcamo
  • Ana Laura Colín-González
  • Abelardo Meneses-García
Article
  • 20 Downloads

Abstract

In this work we estimated the budgetary impact of the samples produced by the biobank of the “Instituto Nacional de Cancerología” (BT-INCan) to set a recuperation fee from the perspective of the Health Ministry of Mexico. The study is an observational retrospective review of the direct medical costs (DMCs) of the processes involved in cryopreservation of the samples collected, on a per sample basis, including materials, laboratory tests, personnel, and administrative costs. Materials and labor costs were determined by information collected from the BT-INCan. DMCs were provided depending on the type of sample: plasma, tissue and biopsy; they were calculated according to the process required to preserve them. Sensitivity analysis was performed using bootstrap. Recuperation costs ranged from 130 to 155 USD. Costs were considered on a 5-year time frame for the maintenance per sample, which is the average time that a sample is kept in the BT-INCan. The cost analysis is perceived as an approximation to the most adequate recuperation fee per sample needed to guarantee the correct development of the BT-INCan. This work provides a basis and valuable information about costs, to enable several health institutions to strategically plan and manage a biobank or even motivate to establish their own biobank.

Keywords

Biobank Pharmacoeconomics Tumor sample preservation Preservation costs Instituto Nacional de Cancerología Tumor Biorepository National cancer control institutes 

Notes

Acknowledgements

The authors appreciate the support of Pedro Arellano, Hector Romero and Gabriel Molina, from the Accounting Department, and Silvia García for secretarial support, all of them from the Instituto Nacional de Cancerología, Mexico.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Andreasson A, Kiss NB, Juhlin CC, Höög A (2013) Long-term storage of endocrine tissues at—80 °C does not adversely affect RNA quality or overall histomorphology. Biopreserv Biobank 11:366–370CrossRefPubMedPubMedCentralGoogle Scholar
  2. Barbareschi M, Cotrupi S, Guarrera GM (2008) Biobanks: instrumentation, personnel and cost analysis. Pathologica 100:139–148PubMedGoogle Scholar
  3. Basik M, Aguilar-Mahecha A, Rousseau C, Diaz Z, Tejpar S, Spatz A, Greenwood CM, Batist G (2013) Biopsies: next-generation biospecimens for tailoring therapy. Nat Rev Clin Oncol 10:437–450CrossRefPubMedGoogle Scholar
  4. Caboux E, Plymoth A, Hainaut P (2007) Common minimum technical standards and protocols for biological resource centres dedicated to cancer research. WorkGroup report 2. IARCGoogle Scholar
  5. Campbell LD, Betsou F, Garcia DL, Giri JG, Pitt KE, Pugh RS, Sexton KC, Skubitz AP, Somiari SB (2012) Development of the ISBER best practices for repositories: collection, storage, retrieval and distribution of biological materials for research. Biopreserv Biobank 10:232–233CrossRefPubMedGoogle Scholar
  6. Enriquez V, Ruiz-Godoy L (2017) Manual de procedimientos del Biobanco del Instituto Nacional de Cancerología. UnpublishedGoogle Scholar
  7. Henderson GE, Cadigan RJ, Edwards TP, Conlon I, Nelson AG, Evans JP, Davis AM, Zimmer C, Weiner BJ (2013) Characterizing biobank organizations in the U.S.: results from a national survey. Genome Med 5:3CrossRefPubMedPubMedCentralGoogle Scholar
  8. Kap M, Oomen M, Arshad S, de Jong B, Riegman P (2014) Fit for purpose frozen tissue collections by RNA integrity number-based quality control assurance at the Erasmus MC tissue bank. Biopreserv Biobank 12:81–90CrossRefPubMedGoogle Scholar
  9. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield EA, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J (2011) Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 119:92–101CrossRefPubMedGoogle Scholar
  10. Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P (2008) Marble Arch International Working Group on biobanking for biomedical research. Biobanking for better healthcare. Mol Oncol 2:213–222CrossRefPubMedPubMedCentralGoogle Scholar
  11. Rogers J, Carolin T, Vaught J, Compton C (2011) Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. J Natl Cancer Inst Monogr 2011:32–38CrossRefPubMedGoogle Scholar
  12. Ruíz-Godoy L, Meneses-García A, Suárez-Roa L, Enriquez V, Lechuga-Rojas R, Reyes-Lira E (2010) Organization of a tumor bank: the experience of the National Cancer Institute of Mexico. Pathobiology 77:147–154CrossRefPubMedGoogle Scholar
  13. Stevenson HS, Wang Y, Muller R, Edelman DC (2015) Long-term stability of total RNA in RNAstable® as evaluated by expression microarray. Biopreserv Biobank 2:114–122CrossRefGoogle Scholar
  14. Vaught J, Rogers J, Carolin T, Compton C (2011) Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 2011:24–31CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Luz María Ruíz-Godoy
    • 1
  • Fabiola Berenice Baez-Revueltas
    • 2
  • María de Lourdes Suarez-Roa
    • 3
  • Héctor Maldonado-Martínez
    • 3
  • Virginia Enriquez-Carcamo
    • 1
  • Ana Laura Colín-González
    • 1
  • Abelardo Meneses-García
    • 4
  1. 1.Banco de TumoresInstituto Nacional de CancerologíaMexico CityMexico
  2. 2.Departamento de Farmacoeconomía y BioestadísticaInstituto Nacional de CancerologíaMexico CityMexico
  3. 3.Departamento de PatologíaInstituto Nacional de CancerologíaMexico CityMexico
  4. 4.Dirección GeneralInstituto Nacional de CancerologíaMexico CityMexico

Personalised recommendations